Safety and monitoring for patients receiving Nirmatrelvir-ritonavir for COVID-19 - ISS-G20 Laboratorium Repository

This series of supportive tools are based on the WHO Therapeutics and COVID-19: living guideline. They are intended to provide supportive information for healthcare workers who are prescribing, administering and monitoring patients receiving nirmatrelvir-ritonavir for non-severe COVID-19.

Entire content available on: https://www.who.int/publications-detail-redirect/WHO-2019-nCoV-Therapeutics-Nirmatrelvir-ritonavir-Poster-C-2023.1